Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
01/2002
01/16/2002EP1171423A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
01/16/2002EP1006984A4 Monohydric alcohol derived urethanes and their use in cosmetic formulations
01/15/2002US6339154 (2-Substituted oxyphenyl) alkanamide derivative, hair growth promoter and external composition for skin using the same
01/15/2002US6339103 For applying to plants, seeds
01/10/2002WO2002002546A1 EPOXYCARBOXYLIC ACID AMIDES, AZIDES AND AMINO ALCOHOLS AND PROCESSES FOR PREPARATION OF α-KETO AMIDES BY USING THEM
01/10/2002WO2002002520A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002518A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002512A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002506A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002505A2 Compounds to treat alzheimer's disease
01/10/2002WO2001052900A3 Novel orthogonally protected amino acid chelators for biomedical applications
01/10/2002US20020004608 N-(4-carbamimidoyl-phenyl)-glycine derivatives
01/10/2002CA2410972A1 Compounds to treat alzheimer's disease
01/10/2002CA2410680A1 Compounds to treat alzheimer's disease
01/10/2002CA2410651A1 Compounds to treat alzheimer's disease
01/09/2002EP1170287A1 Process for preparation of optically active n-substituted azetidine-2-carboxylic acids
01/09/2002EP1170281A1 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof
01/09/2002EP1169298A2 Pharmaceutical compounds
01/09/2002EP0778263B1 Benzene compound and medicinal use thereof
01/09/2002CN1330649A Herbicidal-3-[benzo(ox/thi)azol-7-yl)-1H-pyrimidine-2,4-diones
01/09/2002CN1330637A Compounds useful in treatment of infammatory diseases
01/09/2002CN1330067A 1,1-and 1,2-twice subsitituted cyclopropane compound, preparation method thereof and drug composite containing their
01/09/2002CN1077570C Sulfamate compounds containing N-substituted carbanoyl and process for preparing the same
01/09/2002CN1077567C Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol
01/09/2002CN1077566C 1-phenyl-3-dimethylaminopropane compounds with pharmacological effect
01/08/2002CA2159450C 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors
01/03/2002WO2002000611A2 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists
01/03/2002WO2002000610A1 Fluoroalkyloxy dispersant
01/03/2002WO2002000609A2 2,6,7-substituted tetralines useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity
01/03/2002US20020002292 C7 taxane derivatives and pharmaceutical compositions containing them
01/03/2002US20020002196 Administering a patient an effective amount of hydroxyeicosatetraenoic acid related compounds to treat the dry eye
01/03/2002DE10030891A1 New 3,4-dihydroxybenzyl-substituted carbonic acid derivatives are antioxidants and radical scavengers useful e.g. for preventing skin aging or protecting cosmetic, dermatological or foodstuff compositions against oxidation
01/03/2002DE10029139A1 Verfahren zur Herstellung von Amiden oder Estern A process for producing amides or esters
01/03/2002CA2415873A1 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists
01/02/2002EP1167346A1 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
01/02/2002EP1166781A1 Proteasome inhibitors
01/02/2002EP1165495A1 Resorcinol derivatives
01/02/2002EP1165490A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
01/02/2002EP0996627A4 Method for solution phase synthesis of oligonucleotides and peptides
01/02/2002EP0873308B1 O-carbamoyl-phenylalaninol compounds and their pharmaceutically useful salts
01/01/2002US6335459 Prostaglandin i2 receptor modulators; treating tissue necrosis, premature uterine contraction, gastric ulceration, sexual dysfunction, menstrual pain and improper wound healing, immunoregulation, platelet aggregation or neutrophil function
01/01/2002CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations
01/01/2002CA2083149C Intermediate used for the preparation of deferoxamine
12/2001
12/27/2001WO2001098235A2 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
12/27/2001WO2001063345A9 Photochemically controlled photonic crystal diffraction
12/27/2001WO2001028979A3 Inhibitors of neuraminidases
12/27/2001WO2000064864A9 N-protected amines and their use as prodrugs
12/27/2001US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases
12/27/2001US20010055620 Compaction; particle coatings
12/25/2001US6333427 Extracting optically active form of n-t-butoxycarbonylphenylalanine ester in crude preparation into aliphatic hydrocarbon, recovering ester preparation having improved optical purity
12/25/2001US6333426 Chiral adsorbents and preparation thereof as well as compounds on which the absorbents are based and preparation of the compounds
12/25/2001US6333176 Enzymatic cleavage of c-terminal amino group from peptide amide, deamination with peptide amidase, incubation and inoculation
12/25/2001CA2020988C Acid etch resistant coatings
12/20/2001WO2001096285A1 Beta-amino acid nitrile derivatives
12/20/2001WO2001096282A1 Method for producing amides or esters
12/20/2001WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents
12/20/2001WO2001051456A3 Antibacterial agents
12/20/2001US20010053855 Modified alkoxycarbonyloxypyridine as oligonucleotide blocking agent
12/20/2001DE10028764A1 Carbamate compound, useful as a fragrant additive for cleaning, washing and dishwashing agents, is prepared by reaction of free isocyanate group containing compound with fragrant alcohol
12/19/2001EP1164126A1 Salicylic acid hydrazide derivatives, process and intermediates for their preparation, agents containing them and their use for combatting damaging fungi
12/19/2001EP1164125A1 Adamantane derivatives and processes for the preparation thereof
12/19/2001EP1163262A1 Phenylalanine derivatives
12/19/2001EP1162949A1 Urethane surfactants and their use in personal care formulations
12/19/2001EP0951496B1 Alkyd and aralkyd derivatives of phenolic polymers
12/19/2001EP0721449B1 Inhibitors of beta-amyloid protein production
12/19/2001CN1326930A Method for producing cyclic compounds
12/18/2001US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control
12/18/2001US6331566 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
12/18/2001US6331554 Antipicornaviral compounds, compositions containing them, and methods for their use
12/18/2001US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases
12/18/2001US6331542 Protease inhibitors
12/13/2001WO2001094438A1 Urethane based on organoleptically active aromatic alcohols
12/13/2001WO2001094357A1 Antitumoral compounds
12/13/2001WO2001094307A1 Propanolaminotetralines, preparation thereof and compositions containing same
12/13/2001WO2001094299A1 Benzene derivatives
12/13/2001WO2001094294A1 Fungicides
12/13/2001WO2001034129A3 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
12/13/2001US20010051725 Directly from a halomethyl alcohol protected amine derivative and an amine or alkyl carbamate substituted halomethyl alcohol without having to isolate the toxic boc-epoxide; high yield of pure enantiomorph
12/13/2001US20010051648 Administering to a mammal for the treatment of dry eye or other disorders requiring the wetting of the eye a heteroatom such as nitrogen, oxygen or sulfur interrupted hydroxyeicosatetraenoic acid related compounds
12/13/2001CA2410409A1 Antitumoral compounds
12/12/2001EP1161421A1 Inhibitors of protein tyrosine phosphatase
12/12/2001EP1161416A1 Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 - receptor antagonists
12/12/2001EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001EP1161233A2 Lxr modulators
12/12/2001EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
12/12/2001EP0778827B1 Process for producing a beta-amino alcohol
12/12/2001CN1325847A Compound with electron providing and receiving functional groups
12/12/2001CN1325845A Solidized hybridized vinyl ether containing electron providing compound
12/12/2001CN1076016C O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
12/11/2001US6329377 Enzyme inhibitors for nervous system disorders
12/11/2001US6329359 Substituted benzyl oximino compounds
12/06/2001WO2001092372A2 Monofunctional monomers, radically polymerisable compositions containing them and resins and ophtalmic articles obtained from them
12/06/2001WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001WO2001092213A2 Excitatory amino acid receptor modulators
12/06/2001WO2001092210A1 Compounds for modulating the rage receptor
12/06/2001WO2001091897A1 Process and unit for the continuous preparation of isocyanate-containing polyurethane prepolymers
12/06/2001US20010049387 Use in the treatment of cancer, as tubulin polymerizers and as microtubule stabilization agents.
12/06/2001US20010049374 Amidino derivatives of quinoline and naphthalene
12/06/2001CA2599562A1 Compounds for modulating the rage receptor
12/06/2001CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 157